Koninklijke Philips Operating Expenses 2010-2024 | PHG

Koninklijke Philips annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Koninklijke Philips operating expenses for the quarter ending September 30, 2024 were $4.441B, a 0.18% increase year-over-year.
  • Koninklijke Philips operating expenses for the twelve months ending September 30, 2024 were $18.098B, a 4.1% decline year-over-year.
  • Koninklijke Philips annual operating expenses for 2024 were $18.928B, a 4.35% decline from 2023.
  • Koninklijke Philips annual operating expenses for 2023 were $19.789B, a 2.96% decline from 2022.
  • Koninklijke Philips annual operating expenses for 2022 were $20.392B, a 3.82% increase from 2021.
Koninklijke Philips Annual Operating Expenses
(Millions of US $)
2024 $18,928
2023 $19,789
2022 $20,392
2021 $19,643
2020 $20,553
2019 $19,977
2018 $19,372
2017 $18,382
2016 $25,047
2015 $25,819
2014 $27,789
2013 $28,343
2012 $30,555
2011 $30,005
2010 $31,115
2009 $31,565
Koninklijke Philips Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $4,441
2024-06-30 $3,926
2023-06-30 $4,632
2023-03-31 $5,099
2022-06-30 $4,433
2021-06-30 $4,994
2020-06-30 $4,587
2019-06-30 $4,858
2018-06-30 $4,758
2017-06-30 $4,446
2016-12-31 $6,940
2016-09-30 $6,043
2016-06-30 $6,197
2016-03-31 $5,867
2015-12-31 $7,615
2015-09-30 $6,113
2015-06-30 $6,222
2015-03-31 $5,869
2014-12-31 $6,932
2014-09-30 $7,481
2014-06-30 $6,806
2014-03-31 $6,570
2013-12-31 $8,254
2013-09-30 $6,828
2013-06-30 $6,719
2013-03-31 $6,542
2012-12-31 $9,545
2012-09-30 $7,251
2012-06-30 $6,982
2012-03-31 $6,778
2011-12-31 $8,838
2011-09-30 $7,248
2011-06-30 $7,167
2011-03-31 $6,752
2010-12-31 $9,074
2010-09-30 $7,313
2010-06-30 $7,385
2010-03-31 $7,343
2009-12-31 $8,462
2009-09-30 $7,701
2009-06-30 $8,511
2009-03-31 $6,892
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.527B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.329B 27.30
Boston Scientific (BSX) United States $151.960B 38.05
Stryker (SYK) United States $141.576B 30.43
EssilorLuxottica (ESLOY) France $131.433B 0.00
Medtronic (MDT) Ireland $108.503B 15.84
Lonza Group Ag (LZAGY) Switzerland $51.360B 0.00
Haleon (HLN) United Kingdom $46.382B 26.36
ResMed (RMD) United States $34.859B 26.18
GE HealthCare Technologies (GEHC) United States $31.175B 15.16
Agilent Technologies (A) United States $30.637B 20.24
Terumo (TRUMY) Japan $28.678B 0.00
Zimmer Biomet Holdings (ZBH) United States $20.336B 12.85
Insulet (PODD) United States $17.646B 75.46
Baxter (BAX) United States $15.890B 11.43
Smith & Nephew SNATS (SNN) United Kingdom $11.790B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.119B 17.50
Bio-Rad Laboratories (BIO) United States $6.788B 23.50
Prestige Consumer Healthcare (PBH) United States $4.059B 19.37
Perrigo (PRGO) Ireland $3.496B 10.01
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 28.78
Haemonetics (HAE) United States $3.214B 15.12
Envista Holdings (NVST) United States $2.745B 22.19
GN Store Nord (GNNDY) Denmark $2.260B 15.23
LeMaitre Vascular (LMAT) United States $2.092B 47.73
QuidelOrtho (QDEL) United States $1.928B 16.15
AtriCure (ATRC) United States $1.715B 0.00
Kestra Medical Technologies (KMTS) United States $1.258B 0.00
Green Thumb Industries (GTBIF) United States $1.250B 19.63
BioLife Solutions (BLFS) United States $1.174B 0.00
AdaptHealth (AHCO) United States $1.129B 10.87
Neogen (NEOG) United States $1.092B 13.97
InMode (INMD) Israel $1.003B 9.18
Phibro Animal Health (PAHC) United States $0.765B 11.73
Evolus (EOLS) United States $0.746B 0.00
Curaleaf Holdings (CURLF) Canada $0.596B 0.00
CeriBell (CBLL) United States $0.587B 0.00
Capricor Therapeutics (CAPR) United States $0.574B 0.00
Owens & Minor (OMI) United States $0.541B 4.61
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.493B 0.00
Surmodics (SRDX) United States $0.442B 0.00
Omeros (OMER) United States $0.419B 0.00
Cresco Labs (CRLBF) United States $0.414B 0.00
SNDL (SNDL) Canada $0.389B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.346B 15.02
Verano Holdings (VRNOF) United States $0.307B 0.00
Sanara MedTech (SMTI) United States $0.286B 0.00
Viemed Healthcare (VMD) United States $0.275B 24.82
ZimVie (ZIMV) United States $0.264B 15.78
Aurora Cannabis (ACB) Canada $0.261B 46.40
Cerus (CERS) United States $0.260B 0.00
Canopy Growth (CGC) Canada $0.256B 0.00
OraSure Technologies (OSUR) United States $0.237B 0.00
Quanterix (QTRX) United States $0.235B 0.00
Sanuwave Health (SNWV) United States $0.220B 0.00
High Tide (HITI) Canada $0.196B 0.00
Biote (BTMD) United States $0.194B 4.43
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.89
Brainsway (BWAY) Israel $0.168B 52.29
Organigram Global (OGI) Canada $0.144B 0.00
FitLife Brands (FTLF) United States $0.143B 17.99
Jin Medical (ZJYL) China $0.140B 0.00
Exagen (XGN) United States $0.123B 0.00
Agape ATP (ATPC) $0.121B 0.00
TerrAscend (TSNDF) Canada $0.108B 0.00
MacroGenics (MGNX) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Veru (VERU) United States $0.081B 0.00
Fonar (FONR) United States $0.078B 10.86
Cytosorbents (CTSO) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Zynex (ZYXI) United States $0.067B 0.00
United Health Products (UEEC) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.038B 55.00
Safety Shot (SHOT) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 11.11
Apyx Medical (APYX) United States $0.036B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00